Rx-360 Selects BSI Supply Chain Solutions to Lead Its International Joint Audit Program
Rx-360 announces a strategic partnership with BSI Supply Chain Solutions on Rx-360’s Joint Audit Program designed to enhance patient safety and increase supply chain security through on-the-ground supplier audits.
One of the world’s leading business solutions providers, BSI shares in Rx-360’s commitment to patient safety with its long history ensuring quality and consistency.
BSI will work with Rx-360 to further streamline the audit process and ensure supplier compliance with quality and security standards through verification audits. Overall security will be strengthened through improved supply chain transparency and visibility.
Rx-360, a not-for-profit international consortium representing the world’s leading pharmaceutical and biotech organizations, is committed to protecting patient safety. Recognizing that the globalization of suppliers has added significant complexity to ensuring supplier quality and security of the supply chain, Rx-360 has developed the Joint Audit program to verify and validate supplier compliance, enhance supply chain integrity and improve quality.
This innovative approach will allow multiple companies working with the same business partner to participate in a standardized audit without sacrificing product or process confidentiality. This in turn will significantly reduce audit costs, standardize the audit scope, expand the number of audits conducted, and ultimately reduce supplier audit fatigue while maintaining a high quality standard. The Joint Audit program will ensure audit consistency and transparency from audit scheduling through the required Corrective and Preventive Actions.
BSI was selected for this engagement following a thorough RFP process that considered more than a dozen other highly-qualified auditing firms. Rx-360 has chosen a partner in BSI that has proven its commitment to patient safety through its extensive work in the medical device industry.
With more than 70,000 clients worldwide and more than 150,000 audit days in 150 countries per year, BSI has the resources and infrastructure required to assist Rx-360 with their audit needs and is perfectly positioned to serve as a partner with Rx-360 members’ supplier base.
BSI will utilize its Supplier Verification (VerifEYE) services which will provide local personnel familiar with the local language, customs and traditions to conduct the audits. To ensure consistency of audits, these auditors will be trained by BSI Supply Chain Solutions to standards specific to Rx-360 members’ auditing requirements, including cGMP regulations as well as supply chain security.
Dan Purtell, Senior Vice President, Supply Chain Solutions stated: “By incorporating BSI’s extensive history of corporate auditing, our reputation in the medical device community for patient-safety, and our cutting-edge risk-based approach to supply chain security, we are able to offer Rx-360 a unique solution to meet their needs for efficient and comprehensive supplier auditing. This award will help Rx-360 members significantly reduce ineffective and overlapping audits while maintaining the overarching goal of increasing patient safety.”
Ben Mills, Co-Chair of Rx-360’s Audit Operations Group stated: “Rx-360’s primary mission is to ensure patient safety by maintaining high standards of quality during the manufacturing process. The Joint Audit program will allow consortium members to pool resources and have third-party audits conducted simultaneously while protecting commercially-sensitive and proprietary information. With BSI Supply Chain Solutions, Rx-360 has a partner known for experience, confidentiality, and quality. BSI’s risk-based approach to auditing will enhance effectiveness and supply chain security. The Joint Audit Program offers consortium members, suppliers and manufacturers alike, the opportunity to reduce the audit burden while amplifying product confidence and safety.”
BSI’s integration into Rx-360’s Joint Audit program will begin later this summer.
Related News
-
News Eli Lilly gets ready to launch five new drugs in 2023
Eli Lilly, the American pharmaceutical company (IN, USA) are gearing up for a big year ahead, with hopes to launch five new drugs and capitalise on growing obesity and Alzheimer’s disease markets. -
News Amgen buys Horizon for $27.8 billion in bold step into the rare disease market
Amgen Inc buys pharmaceutical company Horizon Therapeutics in a multibillion-dollar deal, in hopes to capitalise on it's portfolio of drugs in the highly sort after rare disease market. -
News Pharma Supply Chain People Moves
The latest appointments and promotions across the pharmaceutical supply chain. -
News Merck to donate new Ebola vaccine to defend against outbreaks in Uganda
Pharmaceutical giant Merck has announced they will be speeding up the processing of a new vaccine against the latest strain of the Ebola virus, to be donated to a global non-profit organisation for distribution -
News CPHI Podcast Series: Driving innovation with pharmaceutical startups
The latest episode in the CPHI Podcast Series explores how startups are driving innovation by taking high-risk approaches and doing business with greater agility. -
News Greener and efficient processes: Quaternary Ammonium Salts
Quaternary Ammonium Salts play a crucial part in Organic Chemistry processes at many major industries. Discover why.
-
News Biosimilars save patients $11B annually, but barriers to adoption remain in US market
Biosimilars introduce competition into the biologics market, driving down prices and increasing patient access. -
News WHO recommends use of two monoclonal antibody treatments against Ebola
The health body recommended use of treatments by Regeneron and Ridgeback Bio
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance